Gangtok Chronicle

Hematology Analyzers and Reagents Market to Reach $10.33 Billion by 2031, Driven by Advanced Diagnostics and Rising Blood Disorders

 Breaking News
  • No posts were found

Hematology Analyzers and Reagents Market to Reach $10.33 Billion by 2031, Driven by Advanced Diagnostics and Rising Blood Disorders

August 03
15:03 2026
Hematology Analyzers and Reagents Market to Reach $10.33 Billion by 2031, Driven by Advanced Diagnostics and Rising Blood Disorders
Hematology Analyzers and Reagents Market by Product [Instrument (PoC,5 part 6 part), Reagents, Slide Stainers] & Service, Price (High, Mid, Low), Application (Infectious Diseases, Blood Cancer), End User (Hospital, CTL, Govt Lab) Global Forecast to 2031

According to MarketsandMarkets™, The global Hematology Analyzers and Reagents Market is projected to grow from USD 7.57 billion in 2026 to USD 10.33 billion by 2031, at a CAGR of 6.4% during the forecast period. Market growth is driven by the increasing adoption of advanced diagnostic technologies and the rising prevalence of blood-related disorders, including hematological malignancies and infectious diseases.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146

Modern hematology analyzers are transforming diagnostic practices by going beyond traditional complete blood count (CBC) tests. These advanced systems analyze complex cellular characteristics such as morphology, enabling more accurate detection of abnormal cell populations and providing deeper clinical insights.

Hematology Products & Services Segment to Witness Significant Growth

By product and service, the hematology products & services segment is expected to register substantial growth during the forecast period. This segment includes instruments, reagents, consumables, and services that are essential for routine and advanced hematology testing.

The increasing shift toward laboratory automation—such as track-based systems, middleware integration, and auto-validation—has significantly improved operational efficiency and reduced turnaround times. Additionally, the growing volume of diagnostic tests, driven by the rising burden of blood-related diseases, along with the integration of AI-based decision-support systems, is accelerating demand in this segment.

Blood Cancer Segment Dominates Application Landscape

By application, the blood cancer segment is projected to account for the largest share of the market during the forecast period. Conditions such as leukemia, lymphoma, and myeloma require frequent and highly accurate blood testing for diagnosis, monitoring, and treatment evaluation.

The need for continuous monitoring and early detection of hematological malignancies is driving the demand for advanced hematology analyzers and reagents. Increasing global incidence rates of these cancers further reinforce the segment’s dominance.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146

Asia Pacific Emerges as Fastest-Growing Region

The Asia Pacific region is expected to register the highest CAGR in the hematology analyzers and reagents market during the forecast period. Growth in this region is driven by the rising incidence of infectious and chronic diseases, increasing patient population, and expanding access to healthcare services.

The proliferation of private diagnostic laboratories, growing awareness of early disease detection, and adoption of cost-effective and portable point-of-care (POC) analyzers are further contributing to market expansion. Technological advancements tailored for resource-limited settings are also supporting growth across emerging economies in the region.

Competitive Landscape

Key players operating in the hematology analyzers and reagents market include Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

These companies are focusing on innovation, automation, and expanding their product portfolios to enhance diagnostic accuracy and meet the growing demand for advanced hematology solutions.

Related Reports:

In Vitro Diagnostics Market– Global Forecast to 2030

Point of Care Diagnostics Market– Global Forecast to 2031

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagents-market-153222146.html

Categories